(R)-3-Hydroxy-2-oxobutanoicacid

Details

Top
Internal ID 02fa734a-c8ab-4261-a94d-de52988812d1
Taxonomy Organic acids and derivatives > Keto acids and derivatives > Short-chain keto acids and derivatives
IUPAC Name (3R)-3-hydroxy-2-oxobutanoic acid
SMILES (Canonical) CC(C(=O)C(=O)O)O
SMILES (Isomeric) C[C@H](C(=O)C(=O)O)O
InChI InChI=1S/C4H6O4/c1-2(5)3(6)4(7)8/h2,5H,1H3,(H,7,8)/t2-/m1/s1
InChI Key QWZIITCYKKSZGN-UWTATZPHSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C4H6O4
Molecular Weight 118.09 g/mol
Exact Mass 118.02660867 g/mol
Topological Polar Surface Area (TPSA) 74.60 Ų
XlogP -0.60
Atomic LogP (AlogP) -0.98
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
(R)-3-Hydroxy-2-oxobutanoicacid
DTXSID601287552
(R)-3-Hydroxy-2-oxobutanoic acid
Butanoic acid, 3-hydroxy-2-oxo-, (R)-

2D Structure

Top
2D Structure of (R)-3-Hydroxy-2-oxobutanoicacid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6354 63.54%
Caco-2 - 0.8061 80.61%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.7734 77.34%
OATP2B1 inhibitior - 0.8660 86.60%
OATP1B1 inhibitior + 0.9404 94.04%
OATP1B3 inhibitior + 0.9636 96.36%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9694 96.94%
P-glycoprotein inhibitior - 0.9816 98.16%
P-glycoprotein substrate - 0.9849 98.49%
CYP3A4 substrate - 0.7948 79.48%
CYP2C9 substrate + 0.5764 57.64%
CYP2D6 substrate - 0.8813 88.13%
CYP3A4 inhibition - 0.9438 94.38%
CYP2C9 inhibition - 0.8968 89.68%
CYP2C19 inhibition - 0.9689 96.89%
CYP2D6 inhibition - 0.9588 95.88%
CYP1A2 inhibition - 0.9645 96.45%
CYP2C8 inhibition - 0.9964 99.64%
CYP inhibitory promiscuity - 0.9830 98.30%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.5796 57.96%
Carcinogenicity (trinary) Non-required 0.8086 80.86%
Eye corrosion - 0.7304 73.04%
Eye irritation + 0.9679 96.79%
Skin irritation + 0.5345 53.45%
Skin corrosion - 0.5439 54.39%
Ames mutagenesis - 0.8200 82.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8451 84.51%
Micronuclear - 0.7200 72.00%
Hepatotoxicity - 0.6198 61.98%
skin sensitisation - 0.9310 93.10%
Respiratory toxicity - 0.9222 92.22%
Reproductive toxicity - 0.7444 74.44%
Mitochondrial toxicity - 0.8625 86.25%
Nephrotoxicity + 0.5612 56.12%
Acute Oral Toxicity (c) III 0.8348 83.48%
Estrogen receptor binding - 0.9238 92.38%
Androgen receptor binding - 0.9510 95.10%
Thyroid receptor binding - 0.7753 77.53%
Glucocorticoid receptor binding - 0.9001 90.01%
Aromatase binding - 0.8909 89.09%
PPAR gamma - 0.9160 91.60%
Honey bee toxicity - 0.9723 97.23%
Biodegradation + 0.6250 62.50%
Crustacea aquatic toxicity - 0.9700 97.00%
Fish aquatic toxicity - 0.6406 64.06%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 90.57% 85.14%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.61% 96.09%
CHEMBL2581 P07339 Cathepsin D 88.19% 98.95%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 82.07% 100.00%
CHEMBL4040 P28482 MAP kinase ERK2 81.19% 83.82%

Cross-Links

Top
PubChem 15284009
NPASS NPC206169